Log In Sign up
The largest database of trusted experimental protocols

Cd27 alexa594

Manufactured by Thermo Fisher Scientific
Visit Supplier

The CD27 Alexa594 is a fluorescently labeled antibody that binds to the CD27 antigen. It is designed for use in flow cytometry and other immunoassay applications. The Alexa594 fluorophore emits in the red region of the visible spectrum, providing a distinct signal from other commonly used fluorescent labels.

Automatically generated - may contain errors

Lab products found in correlation

Cd3 h7apc sk7, by BD (2 mentions) Cd45ro trpe, by Beckman Coulter (2 mentions) Ctla 4 apc, by Beckman Coulter (2 mentions) Igd pe, by Beckman Coulter (2 mentions) Il 21 alexa 647, by Beckman Coulter (2 mentions) Cd127 cy5pe, by BioLegend (2 mentions) Ccr6 bv785, by Thermo Fisher Scientific (2 mentions) Cd27 bv605, by Thermo Fisher Scientific (2 mentions) Ccr7 bv605, by Thermo Fisher Scientific (2 mentions) Icos pac blue, by Thermo Fisher Scientific (2 mentions) Cd38 bv785, by Thermo Fisher Scientific (2 mentions) Cd20 apc h7, by Beckman Coulter (2 mentions) Igm pe cy5, by Beckman Coulter (2 mentions) Ki 67 alexa700, by Beckman Coulter (2 mentions) Ifng bv421 4, by BioLegend (2 mentions) Tnf α cy7pe, by Thermo Fisher Scientific (2 mentions) Il 2 alexa 700, by Thermo Fisher Scientific (2 mentions) Cd8 bv785, by Thermo Fisher Scientific (2 mentions) Cd19 pac blue, by Thermo Fisher Scientific (2 mentions) Cd154 pe, by Thermo Fisher Scientific (2 mentions)

2 protocols using cd27 alexa594

1

Flow Cytometry Immunophenotyping Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was performed using the following directly conjugated antibodies: (1) BD Biosciences: CD3 H7APC (SK7), CD45RA Cy7PE (L48), CD20 APC-H7 (2H7), CD45RO TRPE (UCHL), CTLA-4 APC (BNI3), IgD PE (IA6-2), IgG APC (G18-145), IgM PE-Cy5 (G20-127), IL-21 Alexa 647 (3A3-N2.1), and Ki-67 Alexa700 (150503); (2) Beckman Coulter: CD127 Cy5PE (R34.34); (3) BioLegend: PD-1 BV711 (EH12.2H7), IFNg BV421 (4S.B3), TNF-α CY7PE (MAb-11), IL-2 Alexa-700 (MQ1-17H12), CCR6 BV785 (G034E3), CD27 Alexa594 (IA4CD27), CD27 BV605 (O323), CCR7-BV605 (G043H7), CD8 BV785 (SK1), ICOS Pac Blue (C398.4A), CD19 Pac Blue (HIB19), CD38 BV785 (HIT2), and CD154 PE (24–31); (4) Invitrogen: CD4 Cy5.5PE (S3.5) and Aqua LIVE/DEAD® amine viability dye; and (5) eBioscience: CXCR5-FITC (MU5UBEE).
Paris R.M., Milagres L.G., Moysi E., Okulicz J.F., Agan B.K., Ganesan A., Petrovas C, & Koup R.A. (2017). Lower Baseline Germinal Center Activity and Preserved Th1 Immunity Are Associated With Hepatitis B Vaccine Response in Treated HIV Infection. Pathogens & Immunity, 2(1), 66-88.
+ Open protocol
+ Expand
2

Comprehensive Immunophenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was performed using the following directly conjugated antibodies: (1) BD Biosciences: CD3 H7APC (SK7), CD45RA Cy7PE (L48), CD20 APC-H7 (2H7), CD45RO TRPE (UCHL), CTLA-4 APC (BNI3), IgD PE (IA6-2), IgG APC (G18-145), IgM PE-Cy5 (G20-127), IL-21 Alexa 647 (3A3-N2.1), and Ki-67 Alexa700 (150503); (2) Beckman Coulter: CD127 Cy5PE (R34.34); (3) BioLegend: PD-1 BV711 (EH12.2H7), IFNg BV421 (4S.B3), TNF-α CY7PE (MAb-11), IL-2 Alexa-700 (MQ1-17H12), CCR6 BV785 (G034E3), CD27 Alexa594 (IA4CD27), CD27 BV605 (O323), CCR7-BV605 (G043H7), CD8 BV785 (SK1), ICOS Pac Blue (C398.4A), CD19 Pac Blue (HIB19), CD38 BV785 (HIT2), and CD154 PE (24-31); (4) Invitrogen: CD4 Cy5.5PE (S3.5) and Aqua LIVE/DEAD® amine viability dye; and (5) eBioscience: CXCR5-FITC (MU5UBEE).
Paris R.M., Milagres L.G., Moysi E., Okulicz J.F., Agan B.K., Ganesan A., Petrovas C, & Koup R.A. (2017). Lower Baseline Germinal Center Activity and Preserved Th1 Immunity Are Associated With Hepatitis B Vaccine Response in Treated HIV Infection. Pathogens & Immunity, 2(1), 66-88.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!